Active Ingredients cover art

Active Ingredients

Active Ingredients

Written by: Fraser Dove International
Listen for free

About this listen

 The Active Ingredients podcast dissects the very essence of exceptional leadership in the life sciences. Our quest is to educate, motivate, and inspire life science professionals to soar to new heights of visionary leadership. Join host Thomas Dove, Co-Founder at Fraser Dove International, as he delves into enriching discussions at the intersection of science and leadership. Wherever you are in your career journey, whether just starting out or leading a team or department, you'll discover a wealth of practical insights and wisdom to carve your leadership journey in the life sciences.Fraser Dove International Economics Management Management & Leadership
Episodes
  • Commercial Leadership In Pharma With Gaurav Jain

    Commercial Leadership In Pharma With Gaurav Jain
    Apr 27 2026
    In this episode of the Active Ingredients podcast, host Thomas Dove interviews Gaurav Jain, Chief Commercial Officer (CCO) at Modavar Pharmaceuticals LLC.Gaurav Jain is a globally experienced commercial leader with over 22 years in the pharmaceutical industry. He has led business development and mergers and acquisitions (M&A) across branded generics, orphan drugs, and multinational companies in markets spanning Asia, the United States, and beyond.In this conversation, Gaurav explains how he entered the industry by chance and built his career by setting clear goals, staying adaptable, and taking on challenges beyond his experience. He also shares how pharma deal structures have shifted away from large upfront payments toward models in which both partners share risk based on a product's performance. He also discusses how senior leaders can protect their organisations from the disruption caused by rising trade barriers and global supply chain instability. Key TakeawaysLearn why clear objective setting forms the foundation of effective leadership in pharmaceutical organisations, and how defining deliverables from day one gives teams direction and prevents wasted effort.Discover how Gaurav Jain's career path from banking into branded generics and M&A shows that subject matter expertise matters less than the ability to work with experts and ask the right questions.Understand how to build high-performing commercial teams by hiring for motivation and mindset rather than industry knowledge alone, and why open dialogue leads to stronger business outcomes.Explore how performance-based deal structures have replaced front-loaded payments in pharmaceutical partnerships, and why shared risk now underpins long-term commercial relationships of all sizes.Identify the steps senior leaders should take to protect their organisations from rising global trade barriers, including diversifying supply chains, monitoring P&L exposure, and engaging proactively with policymakers.Snippets "You don't need to be an expert in every space. What you need to know is how experts perform in their own space, and how to work with the experts to learn enough to work along with the greater organisation.""Even after you close the deal, it's not the end. It's kind of a beginning of another major set of challenges... You might have a great idea, but if you don't really follow up on those ideas during integration, you kind of lose value.""A lot of times I've seen industry professionals look at AI as something that can just shorten the amount of thinking they need to do. AI is not a substitute to strategy, to vision, to thinking, to a challenge."Timestamps & TopicsThe following timestamps are approximations:[00:29] Key Ingredients: Objective setting, adaptability and strategic planning[00:31] Career Path: From banking into the pharmaceutical industry[00:47] Deal Making: What makes M&A a genuine breakthrough for an organisation[00:54] Partnership Evolution: How deal structures have shifted to performance-based models[00:59] Trade Barriers: Navigating geopolitical disruption and supply chain risk[01:07] Future of Leadership: AI, data and the next generation of life sciences leadersResourcesFollow Gaurav Jain on LinkedIn: https://www.linkedin.com/in/gaurav-jain-032b9417/ResourcesFollow Thomas Dove on LinkedIn: https://www.linkedin.com/in/lifesciencesexecutivesearch/Don't Miss an EpisodeSign up to the Active Ingredients podcast at ⁠⁠⁠⁠⁠⁠www.activeingredients.fraserdove.com⁠⁠⁠⁠⁠⁠.Remember to tune into our next episode for more inspiring insights. You can also subscribe to the Active Ingredients podcast on ⁠⁠⁠⁠⁠⁠Apple Podcasts⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠Amazon⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠Spotify⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠YouTube⁠⁠⁠⁠⁠⁠ and other leading podcast platforms.Loved this episode?Share it with your friends, family, or your peers!
    Show More Show Less
    45 mins
  • Why systems beat metrics in life sciences with Gabriel Morelli

    Why systems beat metrics in life sciences with Gabriel Morelli
    Apr 13 2026
    In this episode of the Active Ingredients podcast, host Thomas Dove interviews Gabriel Morelli, Global Freelance Consultant, Advisor and Certified Mentor and Coach.Gabriel Morelli has spent over 25 years in life sciences, spanning generics, CDMOs, consulting and private equity-backed organisations. His career began in Montevideo, was redirected by a British Council scholarship MBA at Cranfield, and has since evolved into an independent advisory practice across the pharma value chain.In this conversation, he explains why most generics and CDMO companies chase the wrong metrics, how to assess a new role within 90 days, and why the freelance leap demands more preparation than most executives expect.Key Takeaways• Learn why integrity, curiosity and genuine interest in people are Gabriel's three non-negotiable leadership qualities, shaped across generics, CDMOs and private equity.• Discover how the systemic view of commercial excellence separates strong generics and CDMO businesses from those that optimise one element while quietly failing everywhere else.• Understand why private equity operates by different rules from corporate life, and why more than half of senior hires struggle once the armies of support are gone.• Explore Gabriel's 90-day rule for assessing whether you can succeed in a new role, and why acting on an honest answer early signals clarity rather than weakness.• Apply the planning principles behind a credible freelance advisory career: a defined niche, consulting skills and commercial fitness before leaving corporate employment.• Gain a clearer view of idea diversity and why teams built around genuine intellectual friction produce stronger outcomes than diversity defined by demographics alone.• Identify why the value most senior executives believe they carry is tied to their company and title, and why most discover this too late to act.• Uncover how Gabriel grew from 5,000 to 22,000 LinkedIn followers through daily publishing, and why a consistent point of view wins more advisory work than any CV.• Take away why adaptability will define the next generation of life science leaders as geopolitics, technology and talent continue to accelerate.Snippets• “The moment you feel that you will not be successful, just push the eject button, disappear, and, focus on something else.”• “It doesn’t really matter if you do something great downstream. If upstream, you’re doing everything wrong… it’s better to do everything average than to be great at KPIs.”• “I’m not so fixated on the diversity, equity and inclusion… To me, what is important is, is ideas… You want people with different ideas with some tensions, some friction, but it needs to be operational.”Timestamps & TopicsThe following timestamps are approximations:• [00:00] –– Intro: Gabriel Morelli’s career across generics, CDMOs, consulting and private equity• [04:14] –– Career Origins: From Montevideo to Cranfield and the MBA that led to life sciences• [18:47] –– Commercial Strategy: The systemic gap in commercial excellence across generics and CDMOs• [21:59] –– Private Equity: Cash discipline, no place to hide, and why most corporate hires struggle• [29:20] –– Quit Fast: The 90-day rule and why staying for appearances is the wrong move• [35:29] –– Second Wave: Defining a niche and why LinkedIn replaces traditional business developmentResources• Follow Gabriel Morelli on LinkedIn: https://www.linkedin.com/in/morelligabriel/• Follow Thomas Dove on LinkedIn: https://www.linkedin.com/in/lifesciencesexecutivesearch/Don't Miss an EpisodeSign up to the Active Ingredients podcast at ⁠⁠⁠⁠⁠www.activeingredients.fraserdove.com⁠⁠⁠⁠⁠.Remember to tune into our next episode for more inspiring insights. You can also subscribe to the Active Ingredients podcast on ⁠⁠⁠⁠⁠Apple Podcasts⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠Amazon⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠Spotify⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠YouTube⁠⁠⁠⁠⁠ and other leading podcast platforms.Loved this episode?Share it with your friends, family, or your peers!
    Show More Show Less
    53 mins
  • From Site Head to Global Leader in Pharma Manufacturing With Laura O'Brien

    From Site Head to Global Leader in Pharma Manufacturing With Laura O'Brien
    Mar 30 2026
    In this episode of the Active Ingredients podcast, host Thomas Dove interviews Laura O'Brien, Global Operations and Quality Executive.Laura O'Brien is one of the most experienced operations and quality leaders in pharma manufacturing, having held VP and SVP roles at Sanofi, Novartis and CSL across four site head roles in the UK and beyond.In this conversation, she shares what it means to be the first female leader on a manufacturing site, how to build and retain world-class teams, and why shifting from direct control to influence is a defining challenge for global pharma leaders. Key Takeaways• Learn why Laura O'Brien's three leadership ingredients (authentic, bold, and connected) are daily disciplines tested by the pressures of senior pharma leadership, not abstract values on a wall.• Discover how mentors become sponsors, and why the most career-defining moments come from being placed in roles you never felt ready for.• Understand why the site head role is the single most important step in a manufacturing leader's career, blending total site accountability with board-level visibility.• Explore how to make the shift from direct control at site level to leading by influence across a global network of pharma manufacturing sites.• Apply Laura's hiring framework: going beyond competency-based interviews to find candidates who will genuinely transform the organisation at this specific point in time.• Gain a new perspective on the number one team concept, and why your strongest professional loyalty should sit with your peer group rather than the team you directly manage.• Uncover what walking the talk really demands from a senior leader, and why authentic role modelling is the only reliable way to build lasting organisational alignment.• Take away Laura's advice on balancing a demanding pharma career with family life, and why trading off rather than trying to do everything perfectly is the smarter long-term strategy.• Identify the difference between a mentor and a sponsor, and why true sponsorship means advocating for someone at board level, not just offering guidance. Snippets• "People will not align behind you if they don't see that you believe in it and [that] you're engaged in it too."• "Don't try to be perfect. In my view, it's impossible if you really want to do all of these things really well. So trade off one against the other at different times."• "Surround yourself with the best people... what I'm really looking for is: is this person going to transform the organisation in the way it needs to be transformed at this point in time?" Timestamps & TopicsThe following timestamps are approximations: • [05:20] -- Intro: Laura O'Brien's background in global pharma operations and quality• [06:48] -- Active Ingredients: Authentic, bold, and connected as the pillars of leadership• [10:24] -- Career Origins: From pharmacy school to a purposeful industrial pharma career• [17:20] -- Site Head: The role that shaped Laura's leadership, including being the first female site head• [26:16] -- Team Building: Hiring for transformation, not just competency• [38:33] -- Global Leadership: Shifting from direct control to influence across a network• [57:54] -- Future of Pharma: AI, patients, and the leadership qualities that will always matter Resources• Follow Laura O'Brien on LinkedIn: https://www.linkedin.com/in/laura-o-brien-4556557/Follow Thomas Dove on LinkedIn: https://www.linkedin.com/in/lifesciencesexecutivesearch/Don't Miss an EpisodeSign up to the Active Ingredients podcast at ⁠⁠⁠⁠www.activeingredients.fraserdove.com⁠⁠⁠⁠.Remember to tune into our next episode for more inspiring insights. You can also subscribe to the Active Ingredients podcast on ⁠⁠⁠⁠Apple Podcasts⁠⁠⁠⁠, ⁠⁠⁠⁠Amazon⁠⁠⁠⁠, ⁠⁠⁠⁠Spotify⁠⁠⁠⁠, ⁠⁠⁠⁠YouTube⁠⁠⁠⁠ and other leading podcast platforms.Loved this episode?Share it with your friends, family, or your peers!
    Show More Show Less
    57 mins
adbl_web_anon_alc_button_suppression_c
No reviews yet